<p>Indivior PLC (LON:INDV - 獲取免費報告) 在週一交易中下跌了 5%。該公司的股價最低跌至 768 便士（9.96 美元），最後報 774 便士（10.04 美元）。在午盤交易中，有 1,059,445 股交易，比平均交易量 544,839 股增加了 94%。該股票此前收盤價為 814.50 便士（10.56 美元）。</p>
<h2>分析師評級變動</h2>
<p>德意志銀行降低了對 Indivior 的目標股價，從 2,350 便士（30.48 美元）降至 1,500 便士（19.45 美元），並在 7 月 9 日星期二的研究報告中為該公司設定了 “買入” 評級。</p>
<p><strong>獲取我們對 Indivior 的最新分析</strong></p>
<h2>Indivior 交易下跌 5.0%</h2>
<p>該公司的 50 天簡單移動平均線為 1,273.11 便士，200 天簡單移動平均線為 1,409.72 便士。公司的資產負債比為 2,790.00，速動比率為 1.52，流動比率為 0.93。該公司的市值為 10.5 億英鎊，市盈率為 25,800.00，市盈增長比率為-5.57，貝塔係數為 0.06。</p>
<h2>關於 Indivior（獲取免費報告）</h2>
<p>Indivior PLC 及其子公司從事在美國、英國和國際市場開發、生產和銷售基於丁丙諾啡的處方藥，用於治療阿片類依賴和併發症。該公司開發藥物用於治療物質使用障礙、嚴重精神疾病和阿片類藥物過量。</p>
<h2>精選故事</h2>
<ul>
<li>五支我們比 Indivior 更看好的股票</li>
<li>什麼是納斯達克證券交易所？</li>
<li>汽車製造商向電動汽車未來的大膽舉措：是時候買入股票了嗎？</li>
<li>3 支引領迷因股復甦的股票</li>
<li>大突破：這隻 ETF 預示着小盤股大漲</li>
<li>如何計算期權利潤</li>
<li>值得關注的主要遊戲股：為什麼現在是一個安全的押注時機</li>
</ul>
<p><em>這則即時新聞警報是由敍事科技和 MarketBeat 的財務數據生成的，旨在為讀者提供最快速和最準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊的審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<p>→ 發佈後，攻擊將會找上我...（來自 Porter &amp; Company）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04NzUx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04NzUx"/></p>
<h2>您現在是否應該投資 1,000 美元購買 Indivior 股票？</h2>
<p>在考慮購買 Indivior 股票之前，您需要聽到這個消息。</p>
<p>MarketBeat 追蹤華爾街評級最高且表現最佳的研究分析師以及他們每天向客户推薦的股票。MarketBeat 已確定了五支頂級分析師悄悄告訴客户現在購買的股票清單... Indivior 不在其中。</p>
<p>儘管 Indivior 目前在分析師中具有 “買入” 評級，但頂級分析師認為這五支股票更值得購買。</p>
<p>查看這五支股票</p>

INDV

<p>Indivior (LON:INDV) 股價週一交易中下跌了 5%，交易量有所增加。德意志銀行下調了對 Indivior 的目標價。該公司開發並銷售用於阿片類藥物依賴治療的處方藥</p>

<p>Indivior PLC (LON:INDV - Get Free Report) fell 5% during trading on Monday . The company traded as low as GBX 768 ($9.96) and last traded at GBX 774 ($10.04). 1,059,445 shares changed hands during mid-day trading, an increase of 94% from the average session volume of 544,839 shares. The stock had previously closed at GBX 814.50 ($10.56).</p>
<div class="lb-trans"><p>Indivior PLC (LON:INDV - 獲取免費報告) 在週一交易中下跌了 5%。該公司的股價最低跌至 768 便士（9.96 美元），最後報 774 便士（10.04 美元）。在午盤交易中，有 1,059,445 股交易，比平均交易量 544,839 股增加了 94%。該股票此前收盤價為 814.50 便士（10.56 美元）。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>Separately, Deutsche Bank Aktiengesellschaft lowered their price target on Indivior from GBX 2,350 ($30.48) to GBX 1,500 ($19.45) and set a &#34;buy&#34; rating for the company in a research report on Tuesday, July 9th.</p>
<div class="lb-trans"><p>德意志銀行降低了對 Indivior 的目標股價，從 2,350 便士（30.48 美元）降至 1,500 便士（19.45 美元），並在 7 月 9 日星期二的研究報告中為該公司設定了 “買入” 評級。</p>
</div><p><strong>Get Our Latest Analysis on Indivior</strong></p>
<div class="lb-trans"><p><strong>獲取我們對 Indivior 的最新分析</strong></p>
</div><h2>Indivior Trading Down 5.0 %</h2>
<div class="lb-trans"><h2>Indivior 交易下跌 5.0%</h2>
</div><p>The firm has a 50 day simple moving average of GBX 1,273.11 and a 200 day simple moving average of GBX 1,409.72. The company has a debt-to-equity ratio of 2,790.00, a quick ratio of 1.52 and a current ratio of 0.93. The firm has a market cap of £1.05 billion, a P/E ratio of 25,800.00, a P/E/G ratio of -5.57 and a beta of 0.06.</p>
<div class="lb-trans"><p>該公司的 50 天簡單移動平均線為 1,273.11 便士，200 天簡單移動平均線為 1,409.72 便士。公司的資產負債比為 2,790.00，速動比率為 1.52，流動比率為 0.93。該公司的市值為 10.5 億英鎊，市盈率為 25,800.00，市盈增長比率為-5.57，貝塔係數為 0.06。</p>
</div><h2>About Indivior (Get Free Report)</h2>
<div class="lb-trans"><h2>關於 Indivior（獲取免費報告）</h2>
</div><p>Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.</p>
<div class="lb-trans"><p>Indivior PLC 及其子公司從事在美國、英國和國際市場開發、生產和銷售基於丁丙諾啡的處方藥，用於治療阿片類依賴和併發症。該公司開發藥物用於治療物質使用障礙、嚴重精神疾病和阿片類藥物過量。</p>
</div><h2>Featured Stories</h2>
<ul>
<li>Five stocks we like better than Indivior</li>
<li>What is the NASDAQ Stock Exchange?</li>
<li>Automaker's Bold Move to an EV Future: Is It Time to Buy Stock?</li>
<li>3 Tickers Leading a Meme Stock Revival</li>
<li>Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks</li>
<li>How to Calculate Options Profits</li>
<li>Major Gaming Stock to Watch: Why It's a Safe Bet Now</li>
</ul>
<div class="lb-trans"><h2>精選故事</h2>
<ul>
<li>五支我們比 Indivior 更看好的股票</li>
<li>什麼是納斯達克證券交易所？</li>
<li>汽車製造商向電動汽車未來的大膽舉措：是時候買入股票了嗎？</li>
<li>3 支引領迷因股復甦的股票</li>
<li>大突破：這隻 ETF 預示着小盤股大漲</li>
<li>如何計算期權利潤</li>
<li>值得關注的主要遊戲股：為什麼現在是一個安全的押注時機</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>這則即時新聞警報是由敍事科技和 MarketBeat 的財務數據生成的，旨在為讀者提供最快速和最準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊的審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><p>→ The attacks will come for me after releasing this… (From Porter &amp; Company)(Ad)</p>
<div class="lb-trans"><p>→ 發佈後，攻擊將會找上我...（來自 Porter &amp; Company）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04NzUx" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8751&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Indivior right now?</h2>
<div class="lb-trans"><h2>您現在是否應該投資 1,000 美元購買 Indivior 股票？</h2>
</div><p>Before you consider Indivior, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮購買 Indivior 股票之前，您需要聽到這個消息。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 追蹤華爾街評級最高且表現最佳的研究分析師以及他們每天向客户推薦的股票。MarketBeat 已確定了五支頂級分析師悄悄告訴客户現在購買的股票清單... Indivior 不在其中。</p>
</div><p>While Indivior currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 Indivior 目前在分析師中具有 “買入” 評級，但頂級分析師認為這五支股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五支股票</p>
</div>

Indivior (LON:INDV) 股價下跌 5%